• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表现为皮肤浆细胞增多症的IgG4相关性疾病:一例报告

IgG4-Related Disease Manifested as Cutaneous Plasmacytosis: A Case Report.

作者信息

Wang Weijia, Kang Xiaojing, Ding Yuan, Mao Lidan, Dilinuer Abudureyimu, Li Wenzheng

机构信息

Department of Dermatology and Venereology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, People's Republic of China.

Xinjiang Clinical Research Center for Dermatologic Diseases, Urumqi, People's Republic of China.

出版信息

Clin Cosmet Investig Dermatol. 2023 Aug 2;16:1997-2004. doi: 10.2147/CCID.S406199. eCollection 2023.

DOI:10.2147/CCID.S406199
PMID:37554302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10404591/
Abstract

BACKGROUND

IgG4-related disease (IgG4-RD) is a rare fibroinflammatory disease that has a high tendency to misdiagnosis in clinics.

CASE PRESENTATION

A 48-year-old man developed a rash with progressive itching 3 years ago after hormone therapy for an ocular "inflammatory pseudotumor". The disease condition of this patient involved multiple organs which involved the skin. The patient was misdiagnosed with other diseases during the period of hospitalization, leading to poor therapeutic effects and repeated skin lesions. The dermatopathological report indicated plasma cell proliferative disorder, with IgG4/IgG exceeding 40% and abnormally elevated serum IgG4 levels. After the patient was diagnosed with IgG4-RD, a series of treatments improved skin lesions, relieved other symptoms, and decreased serum IgG4 levels.

CONCLUSION

IgG4-RD is a highly misdiagnosed disease that deserves the attention of physicians. The patient we reported could be considered a representative case of IgG4-RD that presents with skin lesions. For patients with suspected IgG4-RD, serum IgG4 testing should be performed, and further imaging, serological tests, and pathology examinations are needed to exclude malignancy, infection, and autoimmune diseases.

摘要

背景

IgG4相关性疾病(IgG4-RD)是一种罕见的纤维炎性疾病,在临床上极易误诊。

病例介绍

一名48岁男性在3年前因眼部“炎性假瘤”接受激素治疗后出现皮疹,并伴有进行性瘙痒。该患者的病情累及多个器官,包括皮肤。患者在住院期间被误诊为其他疾病,导致治疗效果不佳且皮肤病变反复出现。皮肤病理报告显示浆细胞增殖性疾病,IgG4/IgG超过40%,血清IgG4水平异常升高。患者被诊断为IgG4-RD后,一系列治疗改善了皮肤病变,缓解了其他症状,并降低了血清IgG4水平。

结论

IgG4-RD是一种极易误诊的疾病,值得医生关注。我们报告的该患者可被视为IgG4-RD伴皮肤病变的典型病例。对于疑似IgG4-RD的患者,应进行血清IgG4检测,还需要进一步的影像学、血清学检查及病理检查以排除恶性肿瘤、感染及自身免疫性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/fbaf2be152e5/CCID-16-1997-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/d52b9fecf4cd/CCID-16-1997-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/ba94d5e20f3f/CCID-16-1997-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/ec0133877877/CCID-16-1997-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/fbaf2be152e5/CCID-16-1997-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/d52b9fecf4cd/CCID-16-1997-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/ba94d5e20f3f/CCID-16-1997-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/ec0133877877/CCID-16-1997-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b5d/10404591/fbaf2be152e5/CCID-16-1997-g0004.jpg

相似文献

1
IgG4-Related Disease Manifested as Cutaneous Plasmacytosis: A Case Report.表现为皮肤浆细胞增多症的IgG4相关性疾病:一例报告
Clin Cosmet Investig Dermatol. 2023 Aug 2;16:1997-2004. doi: 10.2147/CCID.S406199. eCollection 2023.
2
Mass-forming immunoglobulin G4-related cholangitis with atypical pancreatic lesions: a case report of difficult diagnosis.伴有非典型胰腺病变的肿块形成型免疫球蛋白G4相关性胆管炎:一例诊断困难的病例报告
Am J Transl Res. 2023 Mar 15;15(3):2090-2097. eCollection 2023.
3
An inflammatory condition with different faces: immunoglobulin G4-related disease.一种具有不同表现形式的炎症性疾病:免疫球蛋白G4相关性疾病。
Neth J Med. 2016 Mar;74(3):110-5.
4
IgG4-Related Disease Mimicking Unilateral Urothelial Carcinoma: A Rare Case Report and Literature Review.模仿单侧尿路上皮癌的IgG4相关性疾病:1例罕见病例报告及文献复习
Clin Med Insights Case Rep. 2023 Jun 12;16:11795476231180481. doi: 10.1177/11795476231180481. eCollection 2023.
5
IgG4-related disease of the ureter mimicking malignant ureter tumor: a case report and experience sharing.模仿恶性输尿管肿瘤的IgG4相关性输尿管疾病:一例报告及经验分享
AME Case Rep. 2023 Oct 25;8:4. doi: 10.21037/acr-23-33. eCollection 2024.
6
Tumour of the orbit and pterygopalatine fossa: delayed recognition of possible IgG4-related disease.眼眶及翼腭窝肿瘤:对可能的IgG4相关性疾病的延迟识别
Contemp Oncol (Pozn). 2020;24(2):136-139. doi: 10.5114/wo.2020.97638. Epub 2020 Jul 3.
7
Orbital inflammatory pseudotumor revealing multi-organ immunoglobulin G4-related disease.眼眶炎性假瘤伴多器官免疫球蛋白 G4 相关疾病。
Int J Rheum Dis. 2023 Mar;26(3):531-534. doi: 10.1111/1756-185X.14521. Epub 2022 Nov 29.
8
IgG4-Related Chronic Sinonasal Pseudotumor with Refractory Nasal Bleeding: A Case Report.IgG4 相关慢性鼻-鼻窦炎假性肿瘤伴难治性鼻出血:一例报告。
Medicina (Kaunas). 2022 Feb 4;58(2):236. doi: 10.3390/medicina58020236.
9
IgG4-related gastric disease with plasma cell-rich obliterative arteritis accompanied by early-stage gastric cancer: a case report.IgG4相关性胃病伴富含浆细胞的闭塞性动脉炎并早期胃癌:一例报告
Surg Case Rep. 2021 Feb 5;7(1):40. doi: 10.1186/s40792-021-01126-6.
10
IgG4-Related Disease of Bilateral Temporal Bones.双侧颞骨IgG4相关性疾病
Ann Otol Rhinol Laryngol. 2017 Mar;126(3):236-240. doi: 10.1177/0003489416672476. Epub 2016 Oct 11.

引用本文的文献

1
Cutaneous Plasmacytosis: A Rare Dermatological Condition Mimicking Systemic Plasma Cell Disorders.皮肤浆细胞增多症:一种酷似系统性浆细胞疾病的罕见皮肤病。
Cureus. 2024 Dec 18;16(12):e75948. doi: 10.7759/cureus.75948. eCollection 2024 Dec.

本文引用的文献

1
Multidisciplinary diagnosis and management of inflammatory aortic aneurysms.炎性主动脉瘤的多学科诊断和治疗。
J Vasc Surg. 2023 Jul;78(1):231-242.e2. doi: 10.1016/j.jvs.2022.12.024. Epub 2022 Dec 22.
2
Clinical Perspectives on IgG4-Related Disease and Its Classification.关于 IgG4 相关疾病及其分类的临床观点。
Annu Rev Med. 2022 Jan 27;73:545-562. doi: 10.1146/annurev-med-050219-034449. Epub 2021 Oct 20.
3
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
糖皮质激素和类固醇节约药物单药治疗或联合治疗 IgG4-RD:系统评价和网络荟萃分析。
Rheumatology (Oxford). 2020 Apr 1;59(4):718-726. doi: 10.1093/rheumatology/kez380.
4
Characteristics and prognosis of IgG4-related periaortitis/periarteritis: A systematic literature review.IgG4 相关大动脉炎/动脉周围炎的特征和预后:系统文献回顾。
Autoimmun Rev. 2019 Sep;18(9):102354. doi: 10.1016/j.autrev.2019.102354. Epub 2019 Jul 16.
5
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.以来氟米特联合糖皮质激素作为桥接治疗治疗轻中度 IgG4 相关疾病的疗效和安全性:一项前瞻性临床试验。
Int J Rheum Dis. 2019 Aug;22(8):1479-1488. doi: 10.1111/1756-185X.13633. Epub 2019 Jun 27.
6
Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.IgG4 相关疾病的临床表型:两项国际横断面队列研究的分析。
Ann Rheum Dis. 2019 Mar;78(3):406-412. doi: 10.1136/annrheumdis-2018-214603. Epub 2019 Jan 5.
7
IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening.IgG4相关性主动脉周炎/动脉周炎:一种未被充分认识但可能危及生命的疾病。
Mod Rheumatol. 2019 Mar;29(2):240-250. doi: 10.1080/14397595.2018.1546367.
8
Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial.低剂量吗替麦考酚酯治疗 IgG4 相关疾病的疗效和安全性:一项随机临床试验。
Rheumatology (Oxford). 2019 Jan 1;58(1):52-60. doi: 10.1093/rheumatology/key227.
9
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.单独使用糖皮质激素或联合免疫抑制剂治疗 IgG4 相关疾病诱导缓解失败:215 例患者的前瞻性研究。
Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2.
10
Diagnostic and treatment workup for IgG4-related disease.IgG4相关性疾病的诊断与治疗检查
Expert Rev Clin Immunol. 2017 Sep;13(9):867-875. doi: 10.1080/1744666X.2017.1354698. Epub 2017 Jul 24.